BioNTech SE (BNTX) Current Leases (2021 - 2024)

BioNTech SE (BNTX) has 4 years of Current Leases data on file, last reported at $42.2 million in Q4 2024.

• In Q4 2024, Current Leases rose 39.61% year-over-year to $42.2 million; the TTM figure through Dec 2024 stood at $42.2 million (up 39.61% YoY), while the FY2024 annual figure was $42.2 million, up 39.61% from the prior year.
• Current Leases grew to $42.2 million in Q4 2024, from $30.2 million in the prior quarter.
• Across five years, Current Leases topped out at $42.2 million in Q4 2024 and bottomed at $30.2 million in Q4 2023.
• A 4-year average of $35.3 million and a median of $34.3 million in 2021 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2023 — Current Leases dropped 17.68% — and 2024, when it jumped 39.61%.
• Year by year, Current Leases stood at $31.9 million in 2021, then grew by 15.08% to $36.7 million in 2022, then dropped by 17.68% to $30.2 million in 2023, then surged by 39.61% to $42.2 million in 2024.
• The last three Current Leases figures came in at $42.2 million (Q4 2024), $30.2 million (Q4 2023), and $36.7 million (Q4 2022), per Business Quant data.

Peer Comparison